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Objective. To examine the association of self-eﬃcacy, perception of milk production, and lactating women’s use of medication
prescribed to increase breast milk in a cohort of 18–40-year-old mothers over six months. Methods. Mothers (n = 76) attending
community clinics completed the Breastfeeding Self-Eﬃcacy Scale and the Humenick/Hill Lactation Scale, a measure of perceived
milk production, three times. Results. Domperidone, a dopamine antagonist, was used by 28% of participants. On average, those
using domperidone had lower self-eﬃcacy scores than those not using it (P<0.0 5 )a n dw e r em o r el i k e l yt oh a v eu s e df o r m u l a
(Pearson chi-square test statistic = 6.87, df = 1, P<0.05). Breastfeeding self eﬃcacy and perception of milk production were
positively correlated. Conclusion. Breastfeeding assessment conducted prior to prescription of galactogogues is recommended for
mothers and healthy term babies. Following Baby-Friendly hospital protocols and increasing self-eﬃcacy for lactating women may
be most eﬀective in sustaining breastfeeding. Risks and beneﬁts of various galactogogues are discussed.
1.Introduction
Breastfeeding is the optimal form of nutrition for term
and preterm infants [1–3]. Short- and long-term beneﬁts
are associated with reduced sudden infant death syndrome;
positive immunological eﬀects; reductions in the risks of
otitis media, nonspeciﬁc gastroenteritis, severe lower res-
piratory tract infections, atopic dermatitis, obesity, type 1
and 2 diabetes, and childhood leukemia [1, 4]. However,
exclusive breastfeeding, deﬁned by the Public Health Agency
of Canada [5] as “breastfeeding with no other liquid or
solid given to the infant,” is short-lived among lactating
mothers everywhere. In a study comparing results from the
Listening to Mothers II (LTM2; n = 1563) and the Maternal
Experience Survey (MES; n = 6421) conducted in the
United States 2005 and Canada 2006, respectively, rates of
exclusive breastfeedingin hospital postpartum werereported
as 61.2% and 75.4% [6]. At three months this rate dropped
to 42.5% for the LTM2 and 51.7% for the MES. At six
months both surveys reported exclusive breastfeeding rates
of less than 20% [6]. Maintenance of breastfeeding seems
challenging for many women. Perception of insuﬃcient
breastmilk production may contribute to cessation rates [7,
8].
Galactogogues are substances that increase milk volume
by enhancing the rate of milk production and include
both medications such as domperidone, metoclopramide,
and herbs such as fenugreek, blessed thistle, and fennel
(Tables 1 and 2). Common indications for galactogogues
usually occur where lactation is nonexistent or threatened
by known causes. This includes induction of lactation
for adoptive mothers, relactation after weaning, maternal
hypothyroidism,stimulatelactationinwomenwithneonates
in the neonatal intensive care unit, and for mothers who
e x p r e s sm i l kb yh a n do rp u m p[ 7, 9, 12, 13].
Anecdotally, there appears to be a trend for health
care professionals to recommend pharmacological measures
for mothers in the community who present with reported
low milk supply issues. Reported low milk supply may be
alleviated by modifying maternal self-eﬃcacy through skill
improvement and knowledge development [2]. The eﬃcacy
of galactogogues on the maintenance of breastfeeding for2 Obstetrics and Gynecology International
Table 1: Prescription drugs used to increase breastmilk production.
Drug (trade name) Intended use Mechanism Potential side eﬀects
Domperidone (Motilium) Antiemetic treatment of
reﬂux disease
Peripheral
dopamine
antagonist
(i) Maternal cardiac arrhythmia
(ii) Possible neurological side eﬀects in infants
(iii) Dry mouth, abdominal cramps, and headache
(iv) Not approved in the United States
Metoclopramide (Maxeran) Antiemetic Dopamine
antagonist
Drowsiness, restlessness, fatigue, anxiety, insomnia,
depression, sedation, and pseudo-Parkinsonism
Pediatric: prolonged clearance in infants which can
result in high serum levels and a risk for
methemoglobinemia. Side eﬀects are more common
in children
Sulpiride (Eglonyl)
Schizophrenia
Antipsychotic
Antidepressant
Selective dopamine
antagonist
Extrapyramidal reactions and sedation in adults as
well as suspected potential neonatal
endocrinological eﬀects
Excreted in breastmilk
Chlorpromazine (Thorazine) Antipsychotic Increases prolactin Sedation, lethargy, and risk of apnea
Pediatric: SIDS
HGH human growth
hormone (Somatotropin)
Hormone puriﬁed
polypeptide of
recombinant DNA
Stimulates milk
production
Hypoglycemia
Pediatric: absorption from breastmilk is unlikely
THR thyrotrophin releasing
hormone
Treatment of
hypothyroidism
Aﬀects prolactin
release
Theoretically may cause hyperthyroid condition in
infants
Oxytocin (Pitocin Syntocinon) Endogenous
nonapeptide hormone
Stimulates milk
ejection reﬂex
Hypotension, hypertension, water intoxication and
excessive uterine contractions, bradycardia, and
arrhythmias
Pediatric: neonatal jaundice
Metoclopramide [9], Domperidone [10], Motilium [9, 10], and Sulpiride [11].
healthy term newborns and their mothers is unknown.
Galactogogues are more commonly used for re-lactation and
lactogenesis for adoptive mothers and mothers of babies in
neonatal intensive care [13, 14].
High intention and initiation rates of breastfeeding, ex-
clusive or otherwise, are rarely maintained beyond six
months [15]. There are a multitude of reasons women
stop breastfeeding including a lack of self-conﬁdence in
breastfeeding skills, lack of functional support, low spousal
support, desire to smoke, sore nipples, postpartum depres-
sion, and maternal nutritional concerns [15–17]. Women
who have experienced breast surgery, most commonly breast
reduction and augmentation, may not be able to produce
enough milk [18]. Maternal obesity has been implicated in
delayed lactogenesis [19].
The use of formula in hospitals has been linked with low
breastfeeding success rates [20]. The Baby-Friendly Hospital
Initiative (BFHI) was introduced by the World Health
Organization and UNICEF to increase breastfeeding rates
and recommends the reduction of formula use in hospitals
to promote breastfeeding [21]. In 1996, in Belarus, Kramer
et al. conducted a randomized trial using the model of
the Baby-Friendly Hospital initiative as an intervention and
found that exclusive breastfeeding and duration increased
for the ﬁrst year of infants’ lives given exposure to BFHI
compared with standard of care received in control hospitals
[22]. In 2005, it was also found that following BFHI steps,
duration of breastfeeding increased. Of note, their sample
consisted of women who may have been interested in
exclusive breastfeeding and selected hospitals with BFHI
[23]. At the same time, there was high media coverage on
BFHI in Sweden where the study took place so awareness
might have been heightened as breastfeeding rates in non-
BFHI hospitals also rose [23].
The use of formula in hospital and at home has long
been considered a detriment to exclusive breastfeeding and
breastmilk production. However, formula is available in all
hospitals as there are women who do not breastfeed. A
national survey conducted in the United States reported that
women choose not to breastfed because of personal prefer-
ence (66.3%), they face current medical/physical problems
(14.9%), feeding multiples or failed breastfeeding [24–26].
Maintenance of exclusive and partial breastfeeding is
challenging for many women. Worldwide, the most com-
mon reason reported by mothers for early cessation of
breastfeeding is maternal perception of insuﬃcient milk
production [8, 13, 24–32]. Insuﬃcient milk production,
often referred to as insuﬃcient milk syndrome (IMS) was
initially described by Gussler and Briesmeister in 1980 and
was quickly recognized by the World Health Organization as
the world’s largest threat to the continuation of breastfeeding
[8]. The prevalence of perceived insuﬃcient milk production
by mothers is not precisely known but has been reported
between 30% and 80% [32]. This reason is associated with
the highest discontinuation of breastfeeding occurring as
early as 1–4 weeks postpartum [33]. Maternal perception
of insuﬃcient milk production is almost never validated by
measured milk volume but is a prime inﬂuence in maternalObstetrics and Gynecology International 3
Table 2: Herbs commonly associated with galactogogue properties and known interactions.
Herbals Intended use (main eﬀect) Potential side eﬀects Potential interactions Contraindications
Alfalfa∗ (Medicago
sativa)
Tonic
Rejuvenative
Diuretic
Diarrhea
Reversible pancytopenia
Reactivates-systemic
Lupus
Immune modulators Pregnancy
Allergies
Anise∗ (Pimpinella
anisum)
Expectorant
Antispasmodic
Antiseptic
Antiﬂatulence
Seizures
Anticoagulants
MAO inhibitors oral
contraceptives
Pregnancy:
abortifacient
Black seed caraway
(Carum carvi)
Dyspepsia,
antinausea,
antiﬂatulent
incontinence
galactogogue
Contact dermatitis
Weak antispasmodic
activity
Disulﬁram
Pregnant,
breastfeeding due to
antispasmodic eﬀects
Blessed thistle∗
(Cnicus benedictus)
Stimulates menstruation,
antidiarrheal,
antibacterial,
expectorant
galactogogue
Nausea, vomiting
diarrhea, contact
dermatitis
Antacids, H2
antagonists, proton
pump inhibitors,
sucralfate, insulin
Pregnant and
breastfeeding
Fennel∗ (Foeniculum
vulgare)
Expectorant
Antispasmodic
URTI
Seizures
Nausea, pulmonary
edema
Anticonvulsant
Sun exposure Unknown
Fenugreek∗
(Trigonella
foenum-graecum)
GI complaints
URT congestion
Antidiarrheal
Uterine stimulant
Hepatotoxicity
Maple-syrup Urine
diarrhea
Anticoagulants
Antidiabetics
Pregnancy (uterine
stimulant)
breastfeeding
Goat’s rue (Galega
oﬃcinalis)
Diuretic
Galactogogue
Antihyperglycemic
Headache weakness
nervousness None reported
Caution for children,
pregnant, and
breastfeeding patients
Milk thistle∗
(Silybum marianum)
Dyspepsia, liver damage from
chemicals
Nausea, vomiting
diarrhea
Aspirin, cisplatin,
disulﬁram,
hepatotoxic drugs
Pregnant or
breastfeeding patients
Nursing Herbal Medicine Handbook, Nursing Drug Handbook Series, Springhouse Pennsylvania.
∗Often herbs are used in combination, such as mother’s milk tea, various combinations of fenugreek, blessed thistle, anise, coriander, fennel, marshmallow
and other herbs.
decision making to supplement with formula, discontinue
breastfeeding, or use of products that stimulate milk supply.
Galactogogues include prescription and over-the-coun-
ter (OTC) drugs, or complementary and alternative med-
ications (herbal supplements). In the United States, it is
estimatedthat15%ofbreastfeedingwomenhaveusedherbal
galactogogues but the extent of galactogogue use is unknown
for Canadians [34]. The use of herbal galactogogues is cause
for concern because users do not conﬁde in their health
care providers and may mix prescription, OTC, and herbal
medications with potential for adverse eﬀects [35, 36].
A number of herbal supplements are purported to have
galactogogue properties (Table 2). In Canada, Koren et al. of
the Motherisk Program, estimate that between 7 and 55%
of pregnant women use herbal supplements even though the
safety and eﬃcacy of these during pregnancy and lactation
are unknown [37]. A recent American study surveyed herbal
supplement use in pregnant women and reported the 14%
of users did not consider herbal remedies as medications
but natural and therefore benign [38, 39]. However, herbal
supplements often lack standard dosing and preparation,
and known composition [40]. Published research is scant
supportingherbs’eﬀectivenessinincreasingmilkproduction
and more importantly their safety to mother and infant.
Additionally, use of herbal medications may not be disclosed
to conventional health care personnel and clients may
use both prescriptions and herbal supplements courting
potential adverse reactions. While there is some evidence
to support the safety and eﬃcacy of select prescription
drugs, much less exists for herbal supplements, and little
is known regarding drug/herbal supplements interactions
[41].
Women consulting health care professionals for the
perception of insuﬃcient milk production may receive a
recommendation to supplement with formula and/or to use
a prescription medicine. Prescribing drugs for insuﬃcient
milk has recently gained popularity among physicians and
nurse practitioners, although a lack of consensus persists
regardingtheeﬃcacyofprescription galactogoguesandtheir
safety for infants [28, 30, 31]. “Some providers may inappro-
priately recommend galactogogues prior to emphasizing the
primarymeansofincreasingtheoverallrateofmilksynthesis
(i.e., frequent feeding and complete milk removal at regular
intervals).” [7, page 42].4 Obstetrics and Gynecology International
The most commonly prescribed drugs are the gastrok-
inetic agent, domperidone, and the antiemetic, metoclo-
pramide. Until 2010, increased milk production was an
oﬀ-label use for domperidone in Canada but the Federal
Drug Administration in the United States does not recom-
mend it due to reports of arrhythmias in users and the
possibility of adverse eﬀects for infants [8, 42]. The side
eﬀects of domperidone, a dopamine antagonist, include an
increase in prolactin levels, dry mouth, abdominal cramps,
and headache [4, 33, 34]. Domperidone is thought not
to cross the blood-brain barrier but is excreted in breast
milk in low amounts [35]. Although infant exposure to
domperidone is considered insigniﬁcant, evidence is scant
[36]. Other drugs that have been used include antipsychotics
such as sulpiride, chlorpromazine, and hormones including
human growth hormone, thyrotropin releasing hormone
(TRH), and oxytocin nasal spray (Table 1).
In preparation for submission of a national grant we
conducted a pilot study in 2009 using a prospective cohort
design with a convenience sample of mothers. The purpose
of the pilot was to examine self-eﬃcacy, perceived milk pro-
duction, and lactating women’s use of medication prescribed
to increase breastmilk in a cohort of 18–40-year-old mothers
over six months. The pilot allowed testing of the recruitment
strategy and the demographic questionnaire. This study was
approved by the Conjoint Health Research Ethics Board
of the University of Calgary. Permission to access the
community clinics was granted by the Director, Community
Health Centres, Partnerships and Services, Alberta Health
Services.
2.MaterialandMethods
A convenience sample of seventy-six mothers was recruited
from parent drop-in clinics at six community health centres
in Calgary, Alberta, during a three-month period. Women
attended the clinics for breastfeeding support and well baby
checkups. Participants were literate in English, and were
breastfeeding or had attempted to breastfeed a singleton
infant within the previous two months. Exclusion criteria
included mothers with gestational diabetes, previous breast
reductions or augmentations, illnesses such as breast cancer
requiring mastectomy or extended breast lump biopsies,
and those who did not have a telephone. Term, healthy
babies were included in the study. Excluded from the study
were babies less than 37 weeks gestation, those physically
compromised, or those born with abnormalities that would
aﬀect breastfeeding such as cleft lip or palate. Participants
identiﬁed by public health nurses and approached by
research assistants were given a package of questionnaires
assessing breastfeeding self eﬃcacy, maternal perception of
insuﬃcient milk production, and use of galactogogues. They
were surveyed again by telephone at 3 and 6 months after
entry. If a woman weaned within the follow-up contact time,
she was asked to complete the last set of questionnaires.
The Breastfeeding Self-Eﬃcacy Scale, short-form (BSES)
[43], measures a mother’s perceived ability to breastfeed
her baby. Breastfeeding self-eﬃcacy (BSE) is deﬁned as
a mother’s conﬁdence in her perceived ability to breastfeed
thebaby[44].Decreasedself-eﬃcacyisknowntobeinvolved
in cessation of breast-feeding [27, 45]. It has been shown
to be associated with perceived insuﬃcient milk production
[30]. The Hill and Humenick Lactation Scale (HHLS) is
a direct measure of the perception women have of their
o w nm i l kp r o d u c t i o n[ 46]. A demographic information
sheet designed for this study collected data on variables
known to aﬀect breastfeeding, for example, type of delivery,
family support, previous breastfeeding experience, prepara-
tion for breastfeeding, and formula use at hospital and at
home.
The BSES short form is a 14-item self-report instrument
where items are preceded by the phrase “I can always” and
anchored with a 5-point Likert scale where 1 = n o ta ta l l
conﬁdent and 5 = very conﬁdent. Items are summed to
produce a score ranging from 14 to 70 with higher scores
indicating higher levels of breastfeeding self-eﬃcacy [47].
The BSES has been used extensively for a decade with a
variety of populations and is widely published. The short-
form scale has established validity and reliability in English
and three other languages [43, 44, 47] .T h eC r o n b a c h ’ sa l p h a
coeﬃcient for the English short form is 0.94 [43, 47].
Perceived milk production was measured using the
HHLS. It examines maternal commitment, satisfaction, and
perceived infant satiety [46]. The HHLS is a 20-item self-
report instrument where all items are anchored with a 7-
point Likert scale where 1 = strongly disagree and 7 =
strongly agree and can be used for subscale analysis. The
three subscales show moderate to high internal consistency,
Cronbach’s alpha coeﬃcients: 0.75 to 0.98 [48]. Items are
summed to produce a score ranging from 20 to 140 with
higher scores indicating higher levels of commitment and
perceived infant satiety. It has been used with diverse
populationsoverthelastﬁfteenyearsandiswidelypublished
[49, 50].
Information was entered into PAWS version 17 (SPSS,
Inc., Chicago, IL, USA). Descriptive statistics (means, stan-
dard deviations, frequencies, and percentages) were used
to characterize the sample and describe sociodemographic
characteristics. A correlation matrix was calculated to
determine if any socio-demographic characteristics were
signiﬁcantly correlated with each of the dependent variables.
Potential covariates included age, parity, education, marital
status, prior experience breastfeeding, reported support for
breastfeeding, use of formula in hospital, prenatal class
attendance, type of delivery, level of education, support,
and preparation for breastfeeding (i.e., prenatal classes). Chi
square test was used to explore the relationships between
categorical demographic variables. The generalized estimat-
ing equation (GEE) was used to estimate multiple predictors
for BSES and HHLS. This is considered an appropriate
method to identify predictors in repeated measures studies.
Known predictors of breastfeeding continuation such as
delivery experience, prenatal classes, access to breastfeeding
information, and support for partner and family were
controlled for in the model. All comparisons were calculated
with statistical signiﬁcance set at a P < 0.05.Obstetrics and Gynecology International 5
Table 3: Sample characteristics N = 76.
Variable
Number
of
women
n%
Marital status
Married 60 79
Other 16 21
Education years
High school 14 18
Trade school 4 5
Postsecondary 55 72
Type of delivery
Vaginal 51 67
Cesarean section 25 33
Prenatal classes
Have you ever attended prenatal classes? 58 76
Yes
Did you attend prenatal classes for this
pregnancy? 40 53
Yes
Did you ﬁnd prenatal information useful? 67 88
Yes
Previous breastfeeding experience
Yes 32 42
Formula received in hospital
Yes 32 42
When the decision to breastfeed was made?
When I became pregnant 26 34
I was always going to breastfeed 44 58
After prenatal classes 2 3
My partner and I discussed it 4 5
Totals may not add to 100% given missing data.
3. Results
On average the participants were 30 years old (range 19–
40 years), initiation of exclusive breastfeeding was reported
by 57%. At Time 1, entry into the study, 83% reported
breastfeeding and formula feeding and their babies were
between 1 and 20 weeks old. Seventeen per cent were
exclusively breastfeeding. Forty-seven per cent were still
breastfeeding at Time 2 but also using formula. At the end
of Time 3, almost one-third of participants reported use
of domperidone during breastfeeding to increase milk pro-
duction (Table 3).
Table 4 shows the parameter results for predicting BSES
scores and independent variables. Women who used formula
at any time had lower breastfeeding self eﬃcacy than those
who did not use formula (P < 0.05). Women reporting
lower breastfeeding conﬁdence used both formula and
domperidone, two interventions undertaken to ensure their
babies were fed but which may be reﬂective of the lack of
conﬁdence in the ability to exclusively breastfeed. Women
who had conﬁdence in their ability to breastfeed (high BSES
scores) also had high perceived milk production scores (high
HHLS scores).
Women (n = 32) who used formula had lower BSES
scores than those who did not (n = 43, P < 0.001, 95% CI =
−11.66, −3.66). Domperidone was reported by 28% of the
participants. Those who used domperidone had lower BSES
scores than those who did not (P < 0.05, 95% CI = −10.13,
−1.15).
Women reporting lower breastfeeding conﬁdence as
measured by BSES used both formula and domperidone
(Table 4). The GEE results showed that there was no
signiﬁcant association found between education, marital
status, and formula use and HHLS scores.
A positive association between those who used dom-
peridone and formula was found (Pearson chi square, test
statistic = 6.87, df = 1, P < 0.05). As years of education
increased, BSES scores increased (95% CI = 0.628, 3.251,
P < 0.05). Also, prenatal classes speciﬁc in breastfeeding
information increased BSES at Time 1 only (P < 0.05, 95%
CI = 1.455, 14.5).
4. Discussion
The rate of exclusive breastfeeding was low in our study—
a ﬁnding similar in many other international studies.
Breastfeeding combined with formula feeding was the most
commonly reported method of feeding over time. Domperi-
done was prescribed to one third of breastfeeding women in
our study. We were unaware of the particular circumstances
precluding prescription but our inclusion criteria removed
preterm babies, re-lactating women and those with known
health situations that would have knowingly aﬀected breast-
feeding or breast milk yield. There are reports of increasing
domperidone prescription for mothers of preterm babies
(<31 weeks) [51], but the healthy well educated mothers in
our study were from the community and their babies were
term (>37 weeks) so we found the rate of prescription use in
our small study high.
We have reported a 33% rate of surgical delivery and
there may be some justiﬁcation in using dopamine antag-
onists to raise serum prolactin levels in some women who
have had a cesarean section as they may lack a signiﬁcant rise
in prolactin levels [52]. Substances that increase prolactin
levels may be eﬀective for those women with known low
serum prolactin but this test is seldom, if ever, done. There
may be women who are responders and nonresponders to
dopamine antagonists but this would have to be determined
by challenge.
We found that conﬁdence in breastfeeding skills and
perceived breastmilk production were positively correlated
b u tw ea l s or e p o r th i g hu s eo fd o m p e r i d o n e .W ew e r e
unable to determine if use of domperidone contributed
to perceived breastmilk production. This likely had to do
with our inability to access a sample of women earlier in
the postpartum period and prior to use of domperidone.
Women reported that prenatal classes speciﬁcally addressing
breastfeeding had an important inﬂuence on self-eﬃcacy
earlyinthepostpartumperiod,aﬁndingsupportedearlierin6 Obstetrics and Gynecology International
Table 4: Parameter results for predicting BSES and independent variables.
Parameter(s) applied with BSES 95% Wald conﬁdence interval Hypothesis test
Lower Upper Wald chi-square df Sig.
Education .628 3.251 8.399 1 0.004
Formula use −12.801 −2.313 7.977 1 0.005
Formula use over time .135 4.550 4.327 1 0.038
Speciﬁc prenatal breastfeeding classes 1.455 14.513 5.745 1 0.017
Level of signiﬁcance P < 0.05.
aCanadiansampleofbreastfeedingwomen[53].Wesupport
consistency of breastfeeding information oﬀered throughout
the reproductive period, beginning in prenatal classes and
extending into the postpartum period or as long as the
woman continues breastfeeding.
Formula use was also associated with the use of dom-
peridone. We found that the HHLS did not discern between
combination feeding mothers and exclusively breastfeeding
mother. Women can feel satisﬁed and conﬁdent while
combining breastfeeding and formula to feed their babies;
however this combination may decrease duration of breast-
feeding [20].
4.1. Limitations. A limitation of this study is the small
urban convenience sample of women from one region in
Canada. Our sample recruitment was curtailed by the H1N1
pandemic at which time Canadian federal, provincial, and
local health agencies recommended isolation for infants
under 6 months who could not receive H1N1 immunization
[54]. Women stopped attending the drop-in clinics and
community clinic nurses were redeployed to H1N1 immu-
nization clinics and our study ceased prematurely.
Nursesselectingwomenintheclinicmayknowinglyhave
suggestedthosewomenalreadyusingagalactagogueorthose
women who were motivated to participate in a breastfeeding
study may have more readily self-selected to participate in
this study, thereby creating selection bias.
In our study only one woman reported using a herb
(fenugreek) to increase milk production, and this does not
reﬂect the range of herbal use reported elsewhere [34]. We
found higher education associated with higher breastfeeding
self eﬃcacy but this may be a reﬂection of our participants.
Our study sample consisted of well-educated, socially-
advantaged women with excellent medical access, attributes
not shared by all breastfeeding women. Also, participants
entered the study at various times postpartum and recall
bias may have aﬀected responses. The hospitals where our
sample delivered were not Baby-Friendly accredited, which
may have skewed the results of this pilot study as formula
is readily available on the units. Mothers may have received
therecommendationtosupplementwithformulainhospital
which can decrease a mothers overall breastfeeding duration
[20].
4.2.ImplicationsforPractice. Werecommendthatforhealthy
term infants born to healthy mothers, prescription medica-
tion should not be a ﬁrst-line response to maternal perceived
insuﬃcient milk production, a recommendation also held
by the Academy of Breastfeeding Medicine [7]. The increase
in prescription medications may indicate the acceptance of
a “ready ﬁx” subsequent to short assessment visits with
physicians by anxious mothers [55]. Best practice indicates
a physical examination, an assessment of a breastfeeding
session, and an interview prior to suggesting a prescription
medication to address perceived insuﬃcient milk produc-
tion [10, 55]. By following best-practice guidelines, those
women who are experiencing a physiological decrease in
milk production will be appropriately identiﬁed as needing
the pharmacological support to maintain adequate milk
production. Our results concur with others: women with
increased conﬁdence in their breastfeeding ability are more
likely to persist and are less likely to question their milk pro-
duction [24–26, 56]. Combating perceived insuﬃcient milk
remainsanongoingchallengeforallhealthcareprofessionals
workingwithbreastfeedingmothers.Improvinginformation
to postpartum mothers directly related to milk supply
(fullness, timing of feeds), measures of infant satiation
(satiation cues, output), and growth spurts in infants may
help some mothers address breastfeeding concerns. Stressing
the importance of nighttime breastfeeding in the ﬁrst eight
weeks postpartum, when prolactin levels are the highest may
also help to decrease mothers’ perception of insuﬃcient milk
[55].
5. Conclusion
In 2011, Protocol 9 published by the Academy of Breast-
feeding Medicine Protocol Committee stated that caution
should be exercised when recommending drugs to assist
initiation, maintenance, or augmentation of human milk
synthesis. Stronger ties in hospital to Baby-Friendly stan-
dards, increased availability of education for health care
professionals, and standard practice guidelines for breast-
feeding assessmentprior tomedication introduction into the
breastfeeding dyad may promote breastfeeding self-eﬃcacy
and increased satisfaction of mothers and healthier babies.
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